Case number 1:21-cv-01561
ViiV Healthcare Company et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 21, 2023 | 46 | Final Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (apk) (Entered: 03/21/2023) (1) |
| Mar 14, 2023 | 45 | CONSENT JUDGMENT. Signed by Judge Mitchell S. Goldberg on 03/14/2023. (apk) (Entered: 03/14/2023) (3) |
| Mar 3, 2023 | 44 | PROPOSED CONSENT JUDGMENT and Dismissal by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 03/03/2023) (3) |
| Feb 28, 2023 | 43 | [SEALED] SO ORDERED, re 41 Joint STATUS REPORT and Stipulation and Proposed Order to Extend Time. Signed by Judge Mitchell S. Goldberg on 2/28/2023. This order has been emailed to local counsel. (twk) (Entered: 02/28/2023) (0) |
| Feb 24, 2023 | 42 | REDACTED VERSION of 41 Status Report by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 02/24/2023) (2) |
| Feb 17, 2023 | 41 | [SEALED] Joint STATUS REPORT and Stipulation and [Proposed] Order to Extend Time by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) (Entered: 02/17/2023) (0) |
| Jan 25, 2023 | 40 | REDACTED VERSION of 37 Stipulation by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 01/25/2023) (2) |
| Jan 23, 2023 | 39 | [SEALED] SO ORDERED, re 37 STIPULATION and [Proposed] Order Staying Litigation. Ordered by Judge Mitchell S. Goldberg on 1/23/2023. This order has been emailed to local counsel. (twk) (Entered: 01/23/2023) (0) |
| Jan 19, 2023 | 38 | STIPULATION AND ORDER regarding D.I. 36 . Signed by Judge Mitchell S. Goldberg on 1/19/2023. (apk) (Entered: 01/19/2023) (3) |
| Jan 18, 2023 | 37 | [SEALED] STIPULATION and [Proposed] Order Staying Litigation by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) (Entered: 01/18/2023) (0) |
| Jan 16, 2023 | 36 | STIPULATION to extend various deadlines by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) (Entered: 01/16/2023) (3) |
| Dec 15, 2022 | 35 | STIPULATION AND ORDER regarding D.I. 34 . Signed by Judge Mitchell S. Goldberg on 12/15/2022. (apk) (Entered: 12/16/2022) (3) |
| Dec 13, 2022 | 34 | STIPULATION TO EXTEND TIME various deadlines to various dates - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 12/13/2022) (3) |
| Nov 30, 2022 | 33 | STIPULATION AND ORDER regarding D.I. 32 STIPULATION TO EXTEND TIME Rule 26(a) Disclosures and Delaware Default Standard, Paragraph 3 Disclosures to December 15, 2022 and December 22, 2022. Signed by Judge Mitchell S. Goldberg on 11/30/2022. (apk) (Entered: 11/30/2022) (2) |
| Nov 29, 2022 | 32 | STIPULATION TO EXTEND TIME Rule 26(a) Disclosures and Delaware Default Standard, Paragraph 3 Disclosures to December 15, 2022 and December 22, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 11/29/2022) (2) |
| Sep 27, 2022 | 31 | SCHEDULING ORDER: Joinder of Parties due by 1/24/2024. Discovery due by 3/8/2024. Expert Discovery due by 10/11/2024. Status Report due by 4/5/2024. Claim Construction Opening Brief due by 8/16/2023. Claim Construction Answering Brief due by 9/13/2023. Claim Construction Reply Brief due by 10/11/2023. Claim Construction Surreply Brief due by 11/15/2023. A Markman Hearing is set for 1/9/2024 at 10:00 AM in Philadelphia before Judge Mitchell S. Goldberg. Signed by Judge Mitchell S. Goldberg on 09/27/2022. (smg) (Entered: 09/27/2022) (9) |
| Sep 22, 2022 | 30 | ORDER, the Rule 16 Pretrial Conference in the above-captioned matter scheduled for Thursday, September 22, 2022 at 2:00 p.m. is CANCELLED. Signed by Judge Mitchell S. Goldberg on 09/22/2022. (smg) (Entered: 09/22/2022) (1) |
| Sep 16, 2022 | 29 | PROPOSED ORDER Scheduling by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # 1 Letter to The Honorable Mitchell S. Goldberg from Daniel M. Silver, Esq.)(Silver, Daniel) (Entered: 09/16/2022) (Letter to The Honorable Mitchell S. Goldberg from Daniel M. Silver, Esq.) (1) |
| Sep 16, 2022 | 29 | PROPOSED ORDER Scheduling by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # 1 Letter to The Honorable Mitchell S. Goldberg from Daniel M. Silver, Esq.)(Silver, Daniel) (Entered: 09/16/2022) (Main Document) (9) |
| Sep 9, 2022 | 28 | ORDER granting 26 Motion for Pro Hac Vice Appearance of Attorney Daniel O'Boyle and Caitlin Hogan. Signed by Judge Mitchell S. Goldberg on 9/9/2022. (srs) (Entered: 09/09/2022) (2) |
| Sep 8, 2022 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Daniel O'Boyle and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # 1 Certifications for Daniel O'Boyle and Caitlin Hogan)(Joyce, Alexandra) (Entered: 09/08/2022) (Certifications for Daniel O'Boyle and Caitlin Hogan) (2) |
| Sep 8, 2022 | 27 | NOTICE of Appearance of Lisa B. Pensabene by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited (Joyce, Alexandra) (Entered: 09/08/2022) (1) |
| Sep 8, 2022 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Daniel O'Boyle and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # 1 Certifications for Daniel O'Boyle and Caitlin Hogan)(Joyce, Alexandra) (Entered: 09/08/2022) (Main Document) (2) |
| Aug 22, 2022 | 25 | ANSWER to 21 Answer to Complaint, Counterclaim by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited.(Silver, Daniel) (Entered: 08/22/2022) (6) |
| Aug 2, 2022 | 24 | Order (1) Docket Text: ORDER, a Rule 16 Pretrial Conference in the above-captioned matter is scheduled for Thursday, September 22, 2022 at 2:00 p.m. The conference will be conducted via telephone and held on the record. Counsel are directed to dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 8/2/2022. (twk) |
| Aug 1, 2022 | 22 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited. (Phillips, John) |
| Aug 1, 2022 | 21 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, Separate Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) |
| Aug 1, 2022 | 23 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Jun 13, 2022 | 19 | Order (1) Docket Text: ORDER, the parties' Stipulation to Extend Time (ECF No. [17]) is GRANTED. Defendants may file an answer by August 1, 2022. No further extensions will be granted. Signed by Judge Mitchell S. Goldberg on 6/13/2022. (nmg) |
| Jun 13, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephonic Status Conference held on 6/13/2022. (Court Reporter Jimmy Cruz.) (nmg) |
| Jun 9, 2022 | 18 | Order Setting Teleconference (1) Docket Text: ORDER, Upon consideration of the parties' stipulated request for an extension of time (D.I. [17]), it is hereby ORDERED that a telephone status conference is scheduled for June 13, 2022 at 9:30 a.m. Counsel shall dial in as follows: Call: 888-684-8852; Enter access code: 2187450#; Press # to enter as a participant. Signed by Judge Mitchell S. Goldberg on 6/9/2022. (srs) |
| May 25, 2022 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to answer or otherwise respond to the Complaint to August 1, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Apr 8, 2022 | 16 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Xiaomei Cai as co-counsel. Reason for request: No longer with firm. (Bilson, David) |
| Mar 22, 2022 | 15 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER: Defendants shall answer or otherwise respond to the Complaint on or before May 31, 2022. Signed by Judge Mitchell S. Goldberg on 3/22/22. (mal) |
| Mar 16, 2022 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to answer or otherwise respond to the Complaint to May 31, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Feb 15, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Matthew V. Anderson, William A. Rakoczy, and Xiaomei Cai for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Feb 11, 2022 | 13 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [12] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Matthew V. Anderson and Xiaomei Cai. Signed by Judge Mitchell S. Goldberg on 2/11/2022. (nmg) |
| Feb 10, 2022 | 12 | Certification of Xiaomei Cai (1) |
| Feb 10, 2022 | 12 | Certification of Matthew V. Anderson (1) |
| Feb 10, 2022 | 12 | Certification of William A. Rakoczy (1) |
| Feb 10, 2022 | 12 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Matthew V. Anderson and Xiaomei Cai - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of William A. Rakoczy, # (2) Certification of Matthew V. Anderson, # (3) Certification of Xiaomei Cai)(Bilson, David) |
| Feb 4, 2022 | 11 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER re D.I. [10]. Signed by Judge Mitchell S. Goldberg on 2/4/2022. (nmg) |
| Feb 4, 2022 | 10 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Defendants to answer or otherwise respond to the Complaint to March 29, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Jan 28, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.: For Lupin Limited waiver sent on 1/28/2022, answer due 3/29/2022. (Silver, Daniel) |
| Jan 28, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. Lupin Pharmaceuticals, Inc. served on 1/27/2022, answer due 2/17/2022. (Silver, Daniel) |
| Nov 10, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania, due to related cases. Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) |
| Nov 2, 2021 | 1 | Complaint* (1) |
| Nov 2, 2021 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
| Nov 2, 2021 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc, Corporate Parent Shionogi Limited for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (twk) |
| Nov 2, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd.. (twk) |
| Nov 2, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (twk) |
| Nov 2, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than September 21, 2021. Date of Expiration of Patent: December 8, 2029. Thirty Month Stay Deadline: No earlier than March 21, 2024. (twk) |
| Nov 2, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Nov 2, 2021 | 1 | Civil Cover Sheet (2) |
| Nov 2, 2021 | 1 | Exhibit A (32) |
| Nov 2, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3735065.) - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
